Biography

Vice President
Chief Scientific Officer
Katsutoshi Ido
-
Apr. 2003
Joined the Company
-
Apr. 2018
International Project Team Discovery Lead
-
Apr. 2020
Global Gene Therapy Task Force Lead, Discovery, Medicine Creation, Neurology Business Group
-
Jul. 2021
Global Modality Exploration Task Force Lead, Discovery, Medicine Creation, Neurology Business Group
-
Jul. 2022
(Secondees) Director of Cambridge Office, Թϴͷ Innovation Inc.
-
Apr. 2024
Head of InflammAging & Senescence Domain, DHBL
-
Oct. 2024
Discovery Strategy Councilor, DHBL HQs
-
Apr. 2025
Vice President (current)
-
Apr. 2025
Chief Scientific Officer & Head of DHBL Discoverry (current)